• Haleon published a transcript of its H1 2026 results presentation attended by CEO Brian McNamara and CFO Dawn Allen.
• Organic revenue rose 2.6% in H1, accelerating to 3.1% in Q2; full-year guidance reaffirmed at 3%-5% organic growth.
• Adjusted operating profit grew 8.2% at constant currency; gross margin expanded 140 bps; operating margin rose 120 bps constant currency.
• Free cash flow totaled GBP 769 million; GBP 893 million returned via dividends and buybacks; interim dividend set at 2.4p, up 9%.
• Management flagged weaker Respiratory Health demand; noted improving North America trends, stronger Emerging Markets momentum, Middle East conflict pressures.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HALEON plc published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein.